News Digging > Featured > After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant
After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant
After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant,After a staff reduction and the liquidation of VBL’s lead drug candidate, the Israeli biotech is pawning off a manufacturing plant.

After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant

After a staff reduction and the liquidation of VBL’s lead drug candidate, the Israeli biotech is pawning off a manufacturing plant.